Inactive Instrument

Analyst Reco. MaxCyte, Inc. London S.E.

Equities

MaxCyte CEO Maher Masoud buys 100,000 shares	Jun. 11	AN
Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing	Jun. 10	MT
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	May. 03	AN
BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating	Mar. 13	MT
Craig-Hallum Starts Coverage on MaxCyte with Buy Rating, $7 Price Target	Nov. 29	MT
BTIG Adjusts MaxCyte's Price Target to $11 From $10, Reiterates Buy Rating	22-08-15	MT
Stifel Nicolaus Adjusts Price Target for MaxCyte tp $16 From $18, Maintains Buy Rating	22-05-10	MT

No results for this search